1. Home
  2. HOWL vs NA Comparison

HOWL vs NA Comparison

Compare HOWL & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.96

Market Cap

48.1M

Sector

Health Care

ML Signal

HOLD

NA

Nano Labs Ltd

HOLD

Current Price

$2.24

Market Cap

46.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOWL
NA
Founded
2017
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
46.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HOWL
NA
Price
$0.96
$2.24
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
10.4M
121.2K
Earning Date
05-05-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
18.40
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.58
52 Week High
$2.23
$6.10

Technical Indicators

Market Signals
Indicator
HOWL
NA
Relative Strength Index (RSI) 82.17 58.53
Support Level $0.80 $1.64
Resistance Level $1.17 $2.43
Average True Range (ATR) 0.07 0.21
MACD 0.04 0.02
Stochastic Oscillator 89.45 51.56

Price Performance

Historical Comparison
HOWL
NA

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: